Drug Trial Radar · NCT00895011
Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy
Last checked: Nov 20, 2026Latest source record: Oct 1, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
298
Actual
Start
Apr 2009
Primary completion
Apr 2011
Study completion Apr 2011
Sponsor
- Lead sponsor
- VIVUS LLCIndustry
- Sponsor type
- Industry
- First posted
- May 7, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- Male only, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objectives of this study are to evaluate the safety and efficacy of two doses of avanafil in the treatment of adult males for erectile dysfunction following bilateral nerve-sparing radical prostatectomy.
Conditions
- Erectile Dysfunction
Interventions
PlaceboDrug
One dose 30 minutes prior to initiation of sexual activity
AvanafilDrug
One dose 30 minutes prior to initiation of sexual activity
AvanafilDrug
One dose 30 minutes prior to initiation of sexual activity
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Percentage of Sexual Attempts in Which Subjects Are Able to Maintain an Erection of Sufficient Duration to Have Successful IntercourseTime frame: Baseline, Week 12
- The Change in Percentage of Sexual Attempts in Which Subjects Are Able to Insert the Penis Into the Partner's VaginaTime frame: Baseline, Week 12
- Change in International Index of Erectile Function - Erectile Function Domain (IIEF-EF) ScoreTime frame: Baseline, End of Treatment (up to 12 weeks)
Locations
51 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Phoenix, Arizona
Research Site
Laguna Hills, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Sacramento, California
Research Site
Aurora, Colorado
Research Site
Englewood, Colorado
Research Site
Parker, Colorado
Research Site
Washington D.C., District of Columbia
Research Site
Jacksonville, Florida
Research Site
Miami, Florida
Research Site
Trinity, Florida
Research Site
Chicago, Illinois
Research Site
Chicago, Illinois
Research Site
Springfield, Illinois
Research Site
Indianapolis, Indiana
Research Site
New Orleans, Louisiana
Research Site
Shreveport, Louisiana
Research Site
Baltimore, Maryland
Research Site
Towson, Maryland
Research Site
Brighton, Massachusetts
Research Site
Burlington, Massachusetts
Research Site
Jamaica Plain, Massachusetts
Research Site
Ann Arbor, Michigan
Research Site
Hackensack, New Jersey
Research Site
Lawrenceville, New Jersey
Research Site
Brooklyn, New York
Research Site
Brooklyn, New York
Research Site
Garden City, New York
Research Site
Great Neck, New York
Research Site
New York, New York
Research Site
New York, New York
Research Site
New York, New York
Research Site
Poughkeepsie, New York
Research Site
Durham, North Carolina
Research Site
Greensboro, North Carolina
Research Site
Cincinnati, Ohio
Research Site
Cleveland, Ohio
Research Site
Bala-Cynwyd, Pennsylvania
Research Site
Philadelphia, Pennsylvania
Showing 40 of 51 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.